recipharm advanced bio
PrivateLast Round
Take Private
2/15/2021
Last Round Size
$2.3B
Est. Valuation
$3B
Total Funding Raised
$2.8B
Company Overview
A contract development and manufacturing organization (CDMO) focused on advanced therapy medicinal products (ATMPs).
Historical Pricing
Historical view of private secondary pricing and transaction trends.
recipharm advanced bio Comps
Related companies by embedding similarity.
recipharm advanced bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Take Private | 2/15/2021 | ||||
| Follow-on Offering | 5/27/2020 | ||||
| Follow-on Offering | 5/19/2016 | ||||
| IPO | 4/3/2014 | ||||
| Buyout/LBO | 3/1/1995 |
recipharm advanced bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about recipharm advanced bio's valuation, stock price, and market status.